Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00817206
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Renal Failure
Interventions: Drug: LCP-Tacro;   Drug: Prograf

Indicates status has not been verified in more than two years